GLP-1 agonists have transformed weight management, but they come with a retention problem. More than 64% of adults on GLP-1s quit within a year, driven off by nausea, vomiting and
If you caught our previous post about SlimSEB™‡, you already know it is grounded in a foundation of science to support metabolic health, for everyone from biohackers tracking each glucose
You’ve heard us talk about SlimSEB™ before. We’ve been buzzing about it since the earliest data started rolling in, and for good reason.
SlimSEB™ is an advanced, research-backed blend of enzymes,
Millions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty
GLP-1 agonists have rewritten the rules of weight management almost overnight—and in the process created one of the biggest nutrition challenges (and opportunities) formulators have seen in decades.
For brands paying
GLP-1 drugs like Ozempic and Wegovy are reshaping weight management. The results are undeniable—but the side effects are too. That’s why companion solutions aren’t optional anymore. They’re essential.
Why Gut Health